Overview

Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin

Status:
Recruiting

Trial end date:
2024-01-01

Target enrollment:

Participant gender:

Summary

A Blind-adjudication Multi-center Phase II Randomized Clinical Trial of Continuous Low-dose Intravenous Heparin Therapy in Coiled Low-grade Aneurysmal Subarachnoid Hemorrhage Patients with Significant Hemorrhage Burden.

Phase:

Phase 2

Details

Lead Sponsor:

Robert F James, MD, FACS, FAANS
Robert F. James

Collaborator:

Indiana University School of Medicine

Treatments:

Calcium heparin
Heparin